Does magnetic resonance imaging–guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy

Babaian, 2000, A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy, J Urol, 163, 152 Presti, 2003, Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study, J Urol, 169, 125 Eskew, 1997, Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate, J Urol, 157, 199 Jones, 2006, Saturation technique does not improve cancer detection as an initial prostate biopsy strategy, J Urol, 175, 485 Thompson, 2014, Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study, J Urol, 192, 67 Gayet, 2016, The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review, BJU Int, 117, 392, 10.1111/bju.13247 Moore, 2013, Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review, Eur Urol, 63, 125, 10.1016/j.eururo.2012.06.004 Thompson, 2013, The role of magnetic resonance imaging in the diagnosis and management of prostate cancer, BJU Int, 112, 6, 10.1111/bju.12381 Kasivisvanathan, 2013, Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer, J Urol, 189, 860 Siddiqui, 2013, Magnetic resonance imaging/ultrasound–fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059 Wysock, 2014, A prospective, blinded comparison of magnetic resonance (MR) imaging–ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial, Eur Urol, 66, 343, 10.1016/j.eururo.2013.10.048 Sonn, 2014, Value of targeted prostate biopsy using magnetic resonance–ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen, Eur Urol, 65, 809, 10.1016/j.eururo.2013.03.025 Filson, 2016, Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies, Cancer, 122, 884, 10.1002/cncr.29874 Siddiqui, 2015, Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer, JAMA, 313, 390, 10.1001/jama.2014.17942 Borkowetz, 2016, Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy, BJU Int, 118, 213, 10.1111/bju.13461 Meng, 2016, Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion–targeted prostate biopsy outcomes, Eur Urol, 69, 512, 10.1016/j.eururo.2015.06.005 Tonttila, 2016, Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial, Eur Urol, 69, 419, 10.1016/j.eururo.2015.05.024 Wegelin, 2017, Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is There a Preferred Technique?, Eur Urol, 71, 517, 10.1016/j.eururo.2016.07.041 Puech, 2013, Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US–MR fusion guidance versus systematic biopsy—prospective multicenter study, Radiology, 268, 461, 10.1148/radiol.13121501 Yaxley, 2017, Comparison between target MRI in-gantry and cognitive target transperineal or transrectal guided prostate biopsies for PIRADS 3-5 MRI lesions, BJU Int, 10.1111/bju.13971